Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4K Sell
12,433
-4,610
-27% -$8.91K ﹤0.01% 3569
2025
Q4
$39.9K Buy
17,043
+4,551
+36% +$8.65K ﹤0.01% 2888
2025
Q3
$27.1K Buy
+12,492
New +$27.5K ﹤0.01% 2276
2025
Q2
Sell
-2,324
Closed -$11.6K 2739
2025
Q1
$11.6K Buy
2,324
+911
+64% +$7.27K ﹤0.01% 2234
2024
Q4
$10.9K Buy
+1,413
New +$12.4K ﹤0.01% 2135

Other funds holding INAB

XTX Topco's INAB Position: Q1 2026 in Review

XTX Topco reduced its IN8bio (INAB) stake by 27% in Q1 2026, selling an estimated $8.91K and leaving 12,433 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

XTX Topco first reported a position in INAB in Q4 2024 and has held it in 5 quarters since. The position peaked at $39.9K in Q4 2025. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • XTX Topco held 12,433 shares of IN8bio worth $18.4K as of Q1 2026.
  • XTX Topco sold 4,610 IN8bio shares in Q1 2026, an estimated $8.91K.
  • IN8bio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3569 holding.
  • XTX Topco first reported a position in IN8bio in Q4 2024 and has held it in 5 quarters since.
  • XTX Topco's IN8bio position peaked at $39.9K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.